Our study confirmed the increased mRNA levels of TAP1 in ccRCC, both in the TCGA cohort and in the FUSCC cohort, as well as the increased protein expression in the proteomic study. The gene discussed is TAP1; the disease is nonpapillary renal cell carcinoma.